Plasma insulin and growth hormone levels in untreated diabetic children. Blood glucose, plasma insulin, and growth hormone were measured in 28 untreated diabetic children, and the results were compared with those obtained from a control group. Though 2 of the 28 diabetic children were still capable of increasing plasma insulin concentration above the normal fasting range, the insulin response was inadequate in all cases. Growth hormone levels in the fasting diabetic children were not raised; however, in the nonfasting children whose illness was of greater severity they were raised despite the presence of hyperglycaemia.
There is little published information on plasma insulin and growth hormone levels in diabetic children at the time of diagnosis. Two recent reports contain conflicting results. Drash et al. (1968) found low fasting insulin levels, while Parker et al. (1968) reported normal values in newly diagnosed diabetic children. Their growth hormone results were also at variance. Parker et al. (1968) found normal growth hormone levels during fasting and after an oral glucose load or arginine infusion, while Drash et al. (1968) reported raised fasting plasma growth hormone and levels significantly higher than their control group after the intravenous infusion of arginine.
We wish to report the results of plasma insulin and growth hormone estimations obtained before treatment in 28 diabetic children.
Patients and Methods
Investigations were made on 28 newly diagnosed diabetic children, 14 girls and 14 boys, with an age range of 1 year 8 months to 13 years 5 months. None had been treated with insulin at the time of blood collection; 6 were fasted for 12 to 15 hours before blood collection (Cases 1-6). 22 required urgent treatment (Cases 7-28), and venous blood was taken immediately after admission to hospital for glucose, insulin, and growth hormone measurement.
Control data were obtained from 16 non-obese metabolically normal children, 9 boys and 7 girls, whose ages ranged from 2 years 7 months to 15 years 2 months. Venous blood was collected from a peripheral vein with minimal stasis. Aliquots were transferred to fluoride-oxalate tubes for glucose analysis and to heparin tubes for insulin and growth hormone assays. Plasma was stored at -20°C. until assayed.
Blood glucose was determined by an automated glucose-oxidase method described by Discombe (1963) ; plasma insulin was measured by a double antibody radioimmunoassay procedure similar to that described by Morgan and Lazarow (1963) , and the plasma growth hormone was measured by the double antibody radioimmunoassay method of Hartog et al. (1964) .
Results
The blood glucose, plasma insulin, and growth hormone results from the control children and from the diabetic children are shown in Tables I and II. In the control group fasting blood glucose values ranged from 56 mg./100 ml. to 79 mg./100 ml. (mean 64-9 mg./100 ml.). Plasma insulin values ranged from 2 ,tU/ml. to 21 ,U/ml. (mean 9 9 IuU/ ml.). 7 of the 14 control children had plasma growth hormone levels of less than 1 ng./ml. In 6 the concentrations ranged from 1-6 ng./ml., and a high fasting level of 17 ng./ml. was recorded in the remaining control child.
In the fasting diabetic children, blood glucose values ranged from 140 mg./100 ml. to 424 mg./ 100 ml., and in the non-fasting 176 mg./100 ml. to 1820 mg./100 ml. Mean values of insulin in the fasting and in the non-fasting diabetic children were 6 ,uU/ml. and 10 ,uU/ml., respectively; Growth hormone concentrations in the fasting diabetic children were similar to those obtained in the control children, ranging from 1 ng./ml. to 6 ng./ml. Only 1 of the 6 had a value of less than 1 ng./ml. Of the 14 non-fasting, more severely ill diabetic children in whom growth hormone was measured, only 1 had a level of less than 1 ng./ml. Values in the remaining 13 children ranged from 2 ng./ml. to 50 ng./ml., 3 children exceeding the highest level observed in the control group (17 ng./ ml.). Discussion Plasma insulin levels in the newly diagnosed diabetic children were not significantly different from those obtained in the fasting control children, (Baker, Kaye, and Root, 1967) . The role of growth hormone in the pathogenesis of diabetes mellitus has been argued since Young (1937) The less severely ill children who were investigated after overnight fasting had plasma growth hormone concentrations similar to the control children, and only 3 of the more severely ill nonfasted diabetic children had levels greater than the highest recorded in the control group. There is therefore little evidence in our data to support the hypothesis of a causative role for growth hormone in diabetes. However, Hunter and Rigal (1966) have shown that in the 'endocrinologically normal' child growth hormone may be absent from the plasma or too low to measure with available methods for considerable periods during the day. The results obtained in control children reported here were similar. Measurable levels of growth hormone were found in 90% of the diabetic children indicating a more continuous secretion. Johansen and Hansen (1969) have reported persistently raised secretion of growth hormone in diurnal studies of newly diagnosed juvenile diabetics. Unfortunately they did not comment on the clinical state of their patients. In the children reported here higher growth hormone values were recorded in those who were considered too ill for treatment to be delayed. Jacobs and Nabarro (1969) have reported high levels of growth hormone and a return to normal values with treatment in diabetic adults with severe ketosis. Metabolic derangements and stress in the more severely ill diabetic child may therefore be responsible for the increased growth hormone secretion which then exacerbates the situation through its known diabetogenic effect. 
